期刊文献+

慢性肾脏病非透析患者脑钠素与肾功能及左室肥厚的关系 被引量:4

Relationship of brain natriuretic peptide to renal function and left ventricular hypertrophy in patients with chronic kidney disease
原文传递
导出
摘要 目的研究慢性肾脏疾病(CKD)非透析患者脑钠素与肾功能及左室肥厚的关系。方法采用双抗夹心免疫荧光法检测203例 CKD 非透析患者与16例对照组全血脑钠素(BNP)水平,分析其与肾功能及左室心肌重量指数(LVMI)的关系。结果 BNP 水平随着肾小球滤过率(eGFR)的下降逐渐递增[9.35(7.35-15.00)v8 54.40(15.10-173.00)ng/L,P<0.01],Spearman 相关分析提示 CKD 患者 BNP 水平和 eGFR 呈负相关(r=-0.417,P<0.01)。多重回归分析显示 eGFR是影响 BNP 水平的独立危险因素(β=-0.293,P<0.01),lgGFR 每降低1 ml·min^(-1)·(1.73m^2)^(-1),lgBNP 水平就上升0.293 ng/L。CKD 非透析患者与对照组相比左室肥厚发生率明显上升(53.2%vs 10.0%,P<0.05),存在左室肥厚的患者血 BNP 水平显著升高[93.05(37.70-272.00)vs17.30(7.20-63.70)ng/L,P<0.01],LVMI 也是影响 BNP 水平高低的主要原因之一(B=0.266,P<0.01),lgLVMI 每升高1g/m^2,lgBNP 水平就上升0.266 ng/L。结论在 CKD 非透析患者中,eGFR 下降可上调 BNP 水平,虽然肾功能不全可部分干扰 BNP 浓度,但是左室肥厚仍可作为一项影响 BNP 水平升高的独立危险因素。 Objective To clarify the association of brain natriuretic peptide * BNP) with renal function and cardiac dysfunction in non-dialysis-dependent patients with chronic kidney disease (CKD). Methods Fluorescence immuno-assay was used to detect the whole blood concentration of BNP in a cohort of 203 CKD patients and 16 hypertensive controls. Color ultrasonography was conducted to determine the left ventricular mass index (LVMI). Estimated glomerular filtration rate (eGFR) was examined. The relationship of BNP to eGFR and LVMI in these patients. Results There was a trend that the BNP level increased with the decrease of the level of eGFR [ 9.35 (7.35-15.00) vs 54.40 (15.10-173.00) ng/L, P 〈 O. O1 ]. Spearman correlation showed that BNP level was correlated negatively with eGFR(r = -0.417 ,P 〈 0.01 ). Multiple regression analysis showed that eGFR was the independent determinant of BNP (β= -0.293, P 〈0.01 ), and lgBNP concentration increased by 0. 293 ng/L per 1ml·min^-1·(1.73m^2)^-1 reduction in lgGFR. The incidence of LV hypertrophy was much higher in the CKD patients than in the controls (53.2% vs 10.0% ,P 〈0.05 ). BNP level was greater in the patients with LV hypertrophy [93.05 (37.70-272.00) vs 17.30(7.20-63.70) ng/L, P 〈0.01 ], and LVMI had an independent effect on BNP concentration (β= 0.266, P 〈 0.01 ). lgBNP level increased by 0.266 ng/L per 1 g/m^2 increase in lgLVMI. Conclusion The declining eGFR level independently elevates the BNP level in non-dialysis-dependent CKD patients. Although renal dysfunction itself may affects the BNP concentration, LV hypertrophy is a powerful independent determinant of BNP.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第46期3284-3287,共4页 National Medical Journal of China
关键词 利钠肽 肾病 透析 肥大 左心室 Natriuretic peptide, brain Kidney diseases Dialysis Hypertrophy, left ventricular
  • 相关文献

参考文献20

  • 1M Kaisar, N Isbel, DW Johnson. Cardiovascular disease in patients with chronic kidney disease. A clinical review. Minerva Urol Nefrol, 2007,59:281-297.
  • 2Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32:s112-s119.
  • 3Bianchi ME, Farias EF, Bolano J, et al. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines. Ren Fail, 2006, 28:665-670.
  • 4H Dokainish, WA Zoghbi, NM Lakkis, et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. J Am Coll Cardiol,2004,93 : 1130 - 1135.
  • 5Koglin J, Pehlivanli S, Schwaiblamir M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol, 2001,38:1934-1941.
  • 6赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 7赵丽,吴学思,韩智红,胡荣,吕强.B型利钠肽检测对心力衰竭患者的临床评估[J].中华心血管病杂志,2004,32(1):51-52. 被引量:164
  • 8Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005,67:2089-2100.
  • 9Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation, 1977,55:613-618.
  • 10Robert NF, Patrick S, Parfrey, et al. Cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32: s112-s119.

二级参考文献21

  • 1Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988, 332:78-81.
  • 2Mukoyama M, Nakao K, Saito Y, et al. Increased huan brain natriuretic peptide in congestive heart failure. N Engl J Med, 1990,323:757-758.
  • 3Morrison KL,Harrison A,Krishnaswany P,et al. Vtility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol,2002, 39:202-209.
  • 4Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic poptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J, 2001, 141:367-374.
  • 5Joung BY, Park BE, Kim DS, et al. B-type Natriuretic peptide predicts clinical presentations and ventricular overloading in patients with Heart Failure. Yonsei Medical J, 2003, 44:623-634.
  • 6Groenning BA, Nilsson JC, Sondergaavd L, et al. Evaluation of impaired left ventficular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. European Journal of Heart Failure, 2001,3:699-708.
  • 7McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998,351 :9-13.
  • 8Ry SD, Clerico A, Giannessi D, et al. Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method. Scand J Clin Lab Invest, 2000, 60 : 81-90.
  • 9Fonseca C, Sarmento PM, Minez A ,et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Rev Port Cardiol,2004, 23:979-91.
  • 10de Bold A J, Bnmeau BG, de Bold MLK. Mechanical and neurocndocrine regulation of the endocrine heart. Cariovasc Res,1996, 31:7-18.

共引文献344

同被引文献28

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部